Controversies in the management of preschool viral wheeze

Paediatric Respiratory Reviews

Volumn 7, Issue 4, 2006, Pages 293-298

  Panickar, Jayachandran R ^a   Grigg, Jonathan ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

bronchodilators; inhaled corticosteroids; leukotriene receptor antagonists; oral corticosteroids; preschool viral wheeze

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; MONTELUKAST; PLACEBO; PREDNISOLONE; STEROID;

ALLERGIC ASTHMA; ASTHMA; CLINICAL TRIAL; COMMON COLD; DRUG MEGADOSE; HUMAN; INFLAMMATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEROID THERAPY; TREATMENT RESPONSE; WHEEZING;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; COMMON COLD; HUMANS; LEUKOTRIENE ANTAGONISTS; RESPIRATORY SOUNDS; STEROIDS;

EID: 33750611810     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2006.04.010     Document Type: Review

References (33)

1. Kurukulaaratchy R.J., Fenn M.H., Waterhouse L.M., et al. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy 33 (2003) 573-578
2. O'Donnell R.A., and Frew A.J. Is there more than one inflammatory phenotype in asthma?. Thorax 57 (2002) 566-568
3. La Grutta S., Gagliardo R., Mirabella F., et al. Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med 167 (2003) 1490-1495
4. Larche M., Robinson D.S., and Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111 (2003) 450-463 quiz 464
5. Kay A.B. Allergy and allergic diseases. First of two parts. N Engl J Med 344 (2001) 30-37
6. Sears M.R., Burrows B., Flannery E.M., et al. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 325 (1991) 1067-1071
7. Kuehni C.E., Davis A., Brooke A.M., and Silverman M. Are all wheezing disorders in very young (preschool) children increasing in prevalence?. Lancet 357 (2001) 1821-1825
8. Mertsola J., Ziegler T., Ruuskanen O., et al. Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child 66 (1991) 124-129
9. Silverman M., Wang M., Hunter G., and Taub N. Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis. Thorax 58 (2003) 431-434
10. Sporik R., Holgate S.T., and Cogswell J.J. Natural history of asthma in childhood-a birth cohort study. Arch Dis Child 66 (1991) 1050-1053
11. Sporik R., Holgate S.T., Platts-Mills T.A., and Cogswell J.J. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 323 (1990) 502-507
12. Martinez F.D., Wright A.L., Taussig L.M., et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332 (1995) 133-138
13. Park E.S., Golding J., Carswell F., and Stewart-Brown S. Preschool wheezing and prognosis at 10. Arch Dis Child 61 (1986) 642-646
14. Stevens C.A., Turner D., Kuehni C.E., et al. The economic impact of preschool asthma and wheeze. Eur Respir J 21 (2003) 1000-1006
15. Adams NP, Bestall JB, Malouf R et al. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev 2005; (1):CD002738.
16. Adams N, Bestall J, Jones PW. Inhaled fluticasone proprionate for chronic asthma. Cochrane Database Syst Rev 2001; (3):CD003135.
17. Wilson N., Sloper K., and Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 72 (1995) 317-320
18. Connett G., and Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 68 (1993) 85-87
19. Svedmyr J., Nyberg E., Thunqvist P., et al. Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers. Acta Paediatr 88 (1999) 42-47
20. Wilson N.M., and Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child 65 (1990) 407-410
21. Smith M, Iqbal S, Elliot TM et al. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003; (2):CD002886.
22. Horowitz L., Zafrir O., Gilboa S., et al. Acute asthma. Single dose oral steroids in paediatric community clinics. Eur J Pediatr 153 (1994) 526-530
23. Csonka P., Kaila M., Laippala P., et al. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomised, placebo-controlled trial. J Pediatr 143 (2003) 725-730
24. Oommen A., Lambert P.C., and Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 362 (2003) 1433-1438
25. Webb M.S., Henry R.L., and Milner A.D. Oral corticosteroids for wheezing attacks under 18 months. Arch Dis Child 61 (1986) 15-19
26. Braunstahl G.J., Overbeek S.E., Kleinjan A., et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 107 (2001) 469-476
27. Chavasse R, Seddon P, Bara A, McKean M. Short acting beta agonists for recurrent wheeze in children under 2 years of age. Cochrane Database Syst Rev 2002; (3):CD002873.
28. Everard ML, Bara A, Kurian M et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2002; (1):CD001279.
29. McDonald NJ, Bara AI. Anticholinergic therapy for chronic asthma in children over two years of age. Cochrane Database Syst Rev 2003; (3):CD003535.
30. Knorr B., Franchi L.M., Bisgaard H., et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108 (2001) E48
31. Straub D.A., Minocchieri S., Moeller A., et al. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest 127 (2005) 509-514
32. Bisgaard H., Zielen S., Garcia-Garcia M.L., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171 (2005) 315-322
33. Tasche M.J., van der Wouden J.C., Uijen J.H., et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 350 (1997) 1060-1064